Akanda Corp (AKAN) has released an update.
Akanda Corp., an international medical cannabis company, has just announced a new registered direct offering to an accredited investor, involving the sale of common shares and pre-funded warrants estimated to gross approximately $2.5 million. This capital raise, which is expected to close by May 17, 2024, will support the company’s general working capital and corporate expenses. Akanda’s portfolio includes CanMart, a UK-based pharmaceutical distributor, and partnerships aimed at improving patient access to high-quality cannabis products.
For further insights into AKAN stock, check out TipRanks’ Stock Analysis page.
